Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP1 | P03956 | 2/20 | 0.35 |
| ▸ | MMP2 | P08253 | 2/20 | 0.35 |
| ▸ | CA12 | O43570 | 1/20 | 0.35 |
| ▸ | CA1 | P00915 | 1/20 | 0.35 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | MMP9 | P14780 | 1/20 | 0.35 |
| ▸ | MMP8 | P22894 | 1/20 | 0.35 |
| ▸ | CA9 | Q16790 | 1/20 | 0.35 |
| ▸ | PEPD | P12955 | 1/20 | 0.35 |
| ▸ | CA4 | P22748 | 1/20 | 0.34 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.33 |
| ▸ | MMP3 | P08254 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5050593 | 0.84 | CA12 (0.33) | MMP1MMP2CA12CA1CA2 | |
| SCHEMBL29852867 | 0.84 | CA12 (0.33) | MMP1MMP2CA12CA1CA2 | |
| SCHEMBL28455795 | 0.84 | CA12 (0.33) | MMP1MMP2CA12CA1CA2 | |
| SCHEMBL12503915 | 0.82 | PEPD (0.34) | MMP1MMP2CA12CA1CA2 | |
| SCHEMBL16223471 | 0.80 | CA12 (0.37) | MMP1MMP2CA12CA1CA2 | |
| SCHEMBL16223469 | 0.80 | CA12 (0.37) | MMP1MMP2CA12CA1CA2 | |
| SCHEMBL6234114 | 0.77 | — | — | |
| SCHEMBL16647323 | 0.77 | — | — | |
| SCHEMBL7027239 | 0.75 | MMP1 (0.37) | MMP1MMP2CA12CA1CA2 | |
| SCHEMBL7771208 | 0.74 | PKM (0.31) | MMP1CA12CA1CA2MMP8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1551420-A4 | ARYL PHOSPHATE DERIVATIVES WITH SELECTIVE ACTIVITY AGAINST ADENOVIRUS AND HIV | PARKER HUGHES INST (US) | 2007-11-21 | — | — | EP | disclosed |
| EP-1551420-A1 | ARYL PHOSPHATE DERIVATIVES WITH SELECTIVE ACTIVITY AGAINST ADENOVIRUS AND HIV | Parker Hughes Institute (US) | 2005-07-13 | — | — | EP | disclosed |
| EP-1090018-B1 | ARYL PHOSPHATE DERIVATIVES OF d4T HAVING ANTI-HIV ACTIVITY | PARKER HUGHES INST (US) | 2004-09-29 | — | — | EP | disclosed |
| WO-2003105863-A1 | ARYL PHOSPHATE DERIVATIVES WITH SELECTIVE ACTIVITY AGAINST ADENOVIRUS AND HIV | PARKER HUGHES INSTITUTE (US) | 2003-12-24 | — | — | WO | disclosed |
| EP-1090018-A1 | ARYL PHOSPHATE DERIVATIVES OF d4T HAVING ANTI-HIV ACTIVITY | Parker Hughes Institute (US) | 2001-04-11 | — | — | EP | disclosed |
| EP-1068215-A1 | AZT DERIVATIVES EXHIBITING SPERMICIDAL AND ANTI-VIRAL ACTIVITY | Parker Hughes Institute (US) | 2001-01-17 | — | — | EP | disclosed |
| WO-2000000501-A1 | ARYL PHOSPHATE DERIVATIVES OF d4T HAVING ANTI-HIV ACTIVITY | PARKER HUGHES INSTITUTE (US) | 2000-01-06 | — | — | WO | disclosed |
| WO-1999048902-A1 | AZT DERIVATIVES EXHIBITING SPERMICIDAL AND ANTI-VIRAL ACTIVITY | PARKER HUGHES INSTITUTE (US) | 1999-09-30 | — | — | WO | disclosed |